[1]Patent:US2013/150325,2013,A1.Locationinpatent:Paragraph0372;0373;0374;0375;0376
[2]ChemMedChem,2014,vol.9,p.61-66
[1]BioorganicandMedicinalChemistry,2018,vol.26,p.295-307
1085453-44-6
26177-51-5
20570-96-1
1073-62-7
10309-79-2
542-11-0 | Aniline hydrobromide | AA00DA47 | MFCD00035465
53857-59-3 | 2,5-Dibromo-1-methyl-1H-imidazole | AA00DA93 | MFCD01632217
55004-77-8 | 4-Hydroxy-6,7-dimethylcoumarin | AA00DACV | MFCD00239432
50534-45-7 | 1-Ethyl-piperidin-4-ylamine | AA00DAK7 | MFCD03640283
462075-93-0 | 4-[(Butylthio)methyl]-5-methyl-2-furoic acid | AA00DAPF | MFCD00475551
482652-22-2 | 4-Ethyl-5-[(4-methoxyphenoxy)methyl]-4h-1,2,4-triazole-3-thiol | AA00DATV | MFCD02588638
473719-41-4 | Amg-487 | AA00DB1Y | MFCD11111772
448947-81-7 | Glyt2-in-1 | AA00DB5W | MFCD00833175
478030-57-8 | Ethyl 3-[3-(trifluoromethyl)phenyl]-1,2,4-oxadiazole-5-carboxylate | AA00DBB5 | MFCD02102660
55580-08-0 | 7-Bromo-3,4-dihydro-2h-benzo[b]oxepin-5-one | AA00DBGH | MFCD08446940